Sonoma Pharmaceuticals's total assets for Q1 2026 were $14.59M, an increase of 6.58% from the previous quarter. SNOA total liabilities were $10.54M for the fiscal quarter, a 13.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.